PT1687297E - Dímeros da triazina para o tratamento de doenças autoimunes - Google Patents

Dímeros da triazina para o tratamento de doenças autoimunes Download PDF

Info

Publication number
PT1687297E
PT1687297E PT48187439T PT04818743T PT1687297E PT 1687297 E PT1687297 E PT 1687297E PT 48187439 T PT48187439 T PT 48187439T PT 04818743 T PT04818743 T PT 04818743T PT 1687297 E PT1687297 E PT 1687297E
Authority
PT
Portugal
Prior art keywords
treatment
autoimmune diseases
dimers
triazine
triazine dimers
Prior art date
Application number
PT48187439T
Other languages
English (en)
Inventor
Jean-Simon Duceppe
Abdallah Ezzitouni
Christopher Penney
Boulos Zacharie
Lyne Gagnon
Brigitte Grouix
Shaun D Abbott
Jean-François Bienvenu
Alan D Cameron
Daniel Fortin
Karine Houde
Nancie Moreau
Nicole Wilb
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Publication of PT1687297E publication Critical patent/PT1687297E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/54—Three nitrogen atoms
    • C07D251/70—Other substituted melamines
PT48187439T 2003-11-24 2004-11-22 Dímeros da triazina para o tratamento de doenças autoimunes PT1687297E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US52402103P 2003-11-24 2003-11-24

Publications (1)

Publication Number Publication Date
PT1687297E true PT1687297E (pt) 2014-09-18

Family

ID=34619624

Family Applications (1)

Application Number Title Priority Date Filing Date
PT48187439T PT1687297E (pt) 2003-11-24 2004-11-22 Dímeros da triazina para o tratamento de doenças autoimunes

Country Status (13)

Country Link
US (1) US7683061B2 (pt)
EP (1) EP1687297B1 (pt)
JP (1) JP5160788B2 (pt)
AU (1) AU2004291186B2 (pt)
BR (1) BRPI0416843A8 (pt)
CA (1) CA2554635C (pt)
DK (1) DK1687297T3 (pt)
ES (1) ES2501169T3 (pt)
IL (1) IL175814A0 (pt)
MX (1) MXPA06005879A (pt)
PL (1) PL1687297T3 (pt)
PT (1) PT1687297E (pt)
WO (1) WO2005049607A1 (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP2007004095A0 (en) 2005-01-07 2007-08-31 Univ Emory Cxcr4 antagonists for the treatment of hiv infection
JP5038905B2 (ja) * 2005-01-07 2012-10-03 エモリー・ユニバーシテイ 医学的障害の治療用のｃｘｃｒ４拮抗薬
NZ563245A (en) * 2005-05-19 2011-04-29 Prometic Biosciences Inc Triazine compounds and compositions thereof for the treatment of cancers
US8444879B2 (en) * 2006-05-08 2013-05-21 Basf Se Triazine derivatives
WO2008008854A2 (en) * 2006-07-11 2008-01-17 Emory University Cxcr4 antagonists including diazine and triazine structures for the treatment of medical disorders
US9510982B2 (en) 2010-01-13 2016-12-06 Ferno-Washington, Inc. Powered roll-in cots
JP5607241B2 (ja) 2010-05-21 2014-10-15 ケミリア・エービー 新規ピリミジン誘導体
BR112013024378A2 (pt) 2011-03-24 2016-12-13 Chemilia Ab novos derivados de pirimidina
GB201119358D0 (en) * 2011-11-10 2011-12-21 Lewi Paulus J Disubstituted triazine dimers for treatment and/or prevention of infectious diseases
USD751000S1 (en) 2013-06-17 2016-03-08 Ferno-Washington, Inc. Control panel of a patient transport device having surface ornamentation
KR20160087834A (ko) 2013-11-15 2016-07-22 페르노-와싱턴, 인코포레이티드. 자체-작동 코트들
WO2015153936A2 (en) 2014-04-04 2015-10-08 Ferno-Washington, Inc. Methods and systems for automatically articulating cots

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2392607A (en) * 1946-01-08 Preparation of mono-aryl melamines
US2544071A (en) * 1951-03-06 Diethylenetrimelamine and method
GB122458A (en) * 1918-01-22 1919-01-22 Regent Carriage Company Ltd Improvements in or relating to Strainers and like Devices for use on Aircraft.
BE707403A (pt) * 1966-12-03 1968-04-16
JPS4925501B1 (pt) * 1969-07-21 1974-07-01
IT1060458B (it) * 1975-12-18 1982-08-20 Chimosa Chimica Organica Spa Composti piperidil triazinici adatti per la stabilizzazione di polimeri sintetici e procedimento per la loro preparazione
US4269832A (en) * 1978-04-12 1981-05-26 American Cyanamid Company Method of treating arthritic disease
GB2053926B (en) * 1979-07-20 1983-02-23 Atkinson A Albumin extraction by affinity chromatography
CH669305GA3 (pt) * 1981-12-11 1989-03-15
JPS58179263A (ja) * 1982-04-13 1983-10-20 Ube Ind Ltd 難燃性ポリアミド組成物
DE3379050D1 (en) * 1982-08-11 1989-03-02 Ciba Geigy Ag Process for the chemical bond between a stabilising compound and a polymer
DE3440777C2 (de) * 1983-11-14 1998-09-03 Clariant Finance Bvi Ltd Neue sulfonsäuregruppenhaltige, basische Azoverbindungen, deren Herstellung und Verwendung als Farbstoffe
JPS60260655A (ja) * 1984-06-06 1985-12-23 Mitsubishi Chem Ind Ltd ジスアゾ化合物及びセルロース繊維類用ジスアゾ反応性染料
JPS61225232A (ja) * 1985-03-29 1986-10-07 Adeka Argus Chem Co Ltd ポリオレフイン樹脂組成物
DE3518375C1 (de) * 1985-05-22 1986-07-17 Degussa Ag, 6000 Frankfurt Oxymethylencopolymerisat-Formmassen mit verminderter Formaldehyd-Emission bei der thermoplastischen Verarbeitung
JPS61272270A (ja) * 1985-05-28 1986-12-02 Mitsubishi Chem Ind Ltd ジスアゾ系化合物
JPH0619046B2 (ja) * 1985-12-06 1994-03-16 三菱化成株式会社 ジスアゾ化合物およびそれを含有する染料組成物
JPH07109526B2 (ja) * 1987-03-05 1995-11-22 日本化薬株式会社 電子写真用トナ−
EP0310139A3 (en) 1987-10-02 1990-10-31 Fuji Photo Film Co., Ltd. Light-sensitive microcapsule and light-sensitive material employing the same
JPH01154140A (ja) * 1987-12-11 1989-06-16 Fuji Photo Film Co Ltd 感光性マイクロカプセル及び感光材料
GB8801486D0 (en) * 1988-01-22 1988-02-24 Ici Plc Water-soluble dye
EP0333653B1 (de) * 1988-03-16 1994-06-08 Ciba-Geigy Ag Reaktivfarbstoffe, Verfahren zu deren Herstellung und deren Verwendung
US4972010A (en) * 1988-09-21 1990-11-20 Uniroyal Chemical Company, Inc. Substituted triazines
GB9016449D0 (en) * 1990-07-26 1990-09-12 Ici Plc Anionic compounds
GB9016448D0 (en) * 1990-07-26 1990-09-12 Ici Plc Anionic compounds
US5374301A (en) * 1990-07-26 1994-12-20 Zeneca Limited Inks suitable for use in ink jet printing
JPH04295860A (ja) * 1991-03-25 1992-10-20 Ricoh Co Ltd 画像形成方法
IT1252291B (it) * 1991-11-14 1995-06-08 Mini Ricerca Scient Tecnolog Composizioni polimeriche autoestinguenti
IT1252292B (it) * 1991-11-14 1995-06-08 Mini Ricerca Scient Tecnolog Policondensati melamminici
EP0542420A1 (en) * 1991-11-15 1993-05-19 Zeneca Limited Anionic xanthene derivatives and their use in inks
CH684948A5 (de) * 1992-05-13 1995-02-15 Sandoz Ag Basische sulfogruppenhaltige Disazoverbindungen.
JP3210095B2 (ja) * 1992-10-13 2001-09-17 ハッコールケミカル株式会社 有機白色顔料
JPH06329933A (ja) * 1993-05-19 1994-11-29 Canon Inc 染料化合物、これを含有するインク、このインクを用いる記録方法、及び、かかるインクを用いた機器
US5631352A (en) * 1994-06-20 1997-05-20 Ciba-Geigy Corporation Azodyes containing a bridge member based on diamino-substituted triazines
JPH0895281A (ja) * 1994-09-29 1996-04-12 Canon Inc 記録紙及びこれを用いた画像形成方法
JPH10291365A (ja) * 1997-04-21 1998-11-04 Fuji Xerox Co Ltd 多色インクセット及びインクジェット記録方法
JPH1148609A (ja) * 1997-08-04 1999-02-23 Fuji Xerox Co Ltd 画像記録方法及び画像記録装置
US6365719B1 (en) * 1997-09-22 2002-04-02 Clariant Finance (Bvi) Limited Bridged disazo compounds
US6482255B1 (en) * 1997-10-24 2002-11-19 Avecia Limited Disazodyes for ink jet printing
GB9820176D0 (en) * 1998-09-16 1998-11-11 Zeneca Ltd Inks
GB9929318D0 (en) * 1999-12-10 2000-02-02 Prometic Biosciences Limited Macrocyclic compounds and their use
US6153365A (en) * 1999-12-16 2000-11-28 Eastman Kodak Company Photographic processing compositions containing stain reducing agent
ES2335265T3 (es) * 1999-12-28 2010-03-24 Pharmacopeia, Inc. Inhibidores de citoquina, especialmente de tnf-alfa.
JP5142432B2 (ja) * 2000-08-08 2013-02-13 キヤノン株式会社 蛍光インク、インクジェット記録方法、記録ユニット、インクカートリッジ、インクジェット記録装置、蛍光増強方法及び蛍光の長寿命化方法
KR100874622B1 (ko) * 2000-12-14 2008-12-17 후지필름 가부시키가이샤 실질적으로 무색인 광학 이방성 재료
JP4139558B2 (ja) * 2000-12-27 2008-08-27 富士フイルム株式会社 ビストリアジニルアリーレンジアミン誘導体とジアミノスチルベン誘導体とを含有する写真処理組成物及び画像形成方法
JP2002275397A (ja) * 2001-03-16 2002-09-25 Canon Inc インクセット、それを用いたインクジェット記録方法、記録ユニット、インクカートリッジ、及びインクジェット記録装置

Also Published As

Publication number Publication date
DK1687297T3 (da) 2014-09-22
MXPA06005879A (es) 2007-01-26
WO2005049607B1 (en) 2005-07-14
JP2007512259A (ja) 2007-05-17
EP1687297A1 (en) 2006-08-09
US7683061B2 (en) 2010-03-23
ES2501169T3 (es) 2014-10-01
BRPI0416843A (pt) 2007-02-13
CA2554635A1 (en) 2005-06-02
AU2004291186B2 (en) 2012-01-19
AU2004291186A1 (en) 2005-06-02
CA2554635C (en) 2013-06-18
PL1687297T3 (pl) 2014-11-28
US20070149528A1 (en) 2007-06-28
BRPI0416843A8 (pt) 2019-01-02
EP1687297A4 (en) 2009-04-22
EP1687297B1 (en) 2014-06-18
JP5160788B2 (ja) 2013-03-13
IL175814A0 (en) 2006-10-05
WO2005049607A1 (en) 2005-06-02

Similar Documents

Publication Publication Date Title
IL175814A0 (en) Triazine dimers for the treatment of autoimmune diseases
EP1613308A4 (en) CANCER TREATMENT METHODS
PL375532A1 (en) Benzimidazol-1-yl-thiophene compounds for the treatment of cancer
HK1095529A1 (en) Methods for the treatment of endometriosis
AU2003285091A8 (en) Interferon antagonists useful for the treatment of interferon related diseases
IL176206A0 (en) Nogo-a neutralising immunoglobulins for treatment of neurological diseases
HUS2200036I1 (hu) Dihidroimidazolonok alkalmazása kutyák kezelésére
EP1789034A4 (en) COMPOUNDS HAVING A DIPHENYL STRUCTURE FOR THE TREATMENT OF IMMUNE DISEASES
GB0329874D0 (en) Compounds useful for the treatment of diseases
AU2003298911A8 (en) Cyclosporins for the treatment of autoimmune diseases
GB0320238D0 (en) Treatment of disease
EP1611120A4 (en) NEW M THODES FOR THE TREATMENT OF INFLAMMATORY DISEASES
PL377464A1 (pl) Aminoalkoksyindole jako ligandy receptora 5-HT6 do leczenia zaburzeń OUN
PL377601A1 (pl) Sposoby przewidywania zachowania samobójczego podczas leczenia
IL162818A0 (en) Combination therapy for the treatment of bacterialinfections
GB0201025D0 (en) The treatment of degenerative diseases
GB0319182D0 (en) Medical headlight
ZA200606780B (en) Compounds for the treatment of diseases
GB0515544D0 (en) Limb bath
EP1648469A4 (en) ANTIGLUCOCORTICOIDES FOR THE TREATMENT OF CATATONIA
IL175611A0 (en) Combinations for the treatment of proliferative diseases
GB0325957D0 (en) The treatment of pain
GB0210210D0 (en) Treatment of hydrocarbons
GB0315877D0 (en) Compounds for the treatment of disease
HU0302933D0 (en) Treatment of diseases